Xcout Intel
Avenzo Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Avenzo Therapeutics among oncology companies — ranked by similarity to what Avenzo Therapeutics actually does, not by market-cap band.
Subscribe to see Avenzo Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Avenzo Therapeutics
Avenzo Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to developing next-generation oncology treatments.
Avenzo Therapeutics at a glance
Avenzo Therapeutics is an oncology company headquartered in United States. Its most recent funding round, Series A-1, raised $60M in September 2025. Xcout tracks 12 named people at Avenzo Therapeutics, including Athena Countouriotis, M.D. (Chief Executive Officer).
Avenzo Therapeutics leadership
- Athena Countouriotis, M.D.Chief Executive Officer
- Athena CountouriotisExecutive Officer
- Brian SunExecutive Officer
- Mohammad HirmandExecutive Officer
- Paolo TombesiExecutive Officer
- Scott LipmanExecutive Officer
6 more named people on record for Avenzo Therapeutics, with roles, board committees and tenure — see the full roster →
Avenzo Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A-1 | $60M | 13 named | |
| Series B | $150M | — | |
| SEC Form D filing | $385.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Avenzo Therapeutics news
- AcquisitionRallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement
- AcquisitionRallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement - Business Wire
Top 12 Avenzo Therapeutics competitors
Ranked by semantic similarity — how close each company is to Avenzo Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Drug Discovery
OncoMyx Therapeutics, Inc. is a biotechnology company headquartered in Phoenix, Arizona, that develops innovative oncolytic immunotherapies to target and destroy tumors.
Biopharmaceuticals
ARMO BioSciences is a late-stage immuno-oncology company that develops a pipeline of novel, proprietary product candidates designed to activate the immune system of cancer patients to recognize and eradicate tumors.
Biopharma
Arch Oncology is a clinical-stage immuno-oncology company headquartered in Brisbane, California, with an additional scientific research laboratory in St. Louis, Missouri. The company develops antibody-based cancer therapies.
Biopharmaceuticals
Amunix Pharmaceuticals, Inc. is a biopharmaceutical company located in South San Francisco and Mountain View, California. The company focuses on oncology, leveraging its proprietary Pro-XTEN technology platform to engineer novel protein therapeutics.
Biopharmaceuticals
Carrick Therapeutics is a biopharmaceutical company with its corporate headquarters located in Boston, Massachusetts, focused on discovering and developing innovative cancer treatments.
Drug Discovery
Peptomyc is a clinical-stage biotechnology company headquartered in Barcelona, Spain, specializing in the development of protein and peptide therapeutics for cancer.
Drug Discovery
Ona Therapeutics is a biotechnology company founded in 2019 and headquartered in Barcelona, Spain, specializing in the design of first-in-class biotherapeutics and ADCs to attack advanced cancer.
Drug Discovery
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients. Founded in 2024, the company is based in Morris Plains, New Jersey.
Biopharmaceuticals
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for oncology and is based in Toronto, Canada, with a corporate office in Boston, Massachusetts.
Drug Discovery
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company headquartered in South San Francisco, California. It specializes in developing novel T-cell engaging therapies for the treatment of cancer.
Drug Discovery
PAQ Therapeutics is a clinical-stage biotechnology company that utilizes autophagy to develop small-molecule KRAS degraders for the treatment of lethal cancers. The company's research focuses on restoring health and curing diseases that currently lack effective treatment options.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Avenzo Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Avenzo Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →